Biotechnology Fund Investor Fund Market Value

RYOIX Fund  USD 66.38  0.09  0.14%   
Biotechnology Fund's market value is the price at which a share of Biotechnology Fund trades on a public exchange. It measures the collective expectations of Biotechnology Fund Investor investors about its performance. Biotechnology Fund is trading at 66.38 as of the 5th of March 2025; that is 0.14 percent down since the beginning of the trading day. The fund's open price was 66.47.
With this module, you can estimate the performance of a buy and hold strategy of Biotechnology Fund Investor and determine expected loss or profit from investing in Biotechnology Fund over a given investment horizon. Check out Biotechnology Fund Correlation, Biotechnology Fund Volatility and Biotechnology Fund Alpha and Beta module to complement your research on Biotechnology Fund.
Symbol

Please note, there is a significant difference between Biotechnology Fund's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotechnology Fund is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotechnology Fund's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biotechnology Fund 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biotechnology Fund's mutual fund what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biotechnology Fund.
0.00
09/06/2024
No Change 0.00  0.0 
In 5 months and 30 days
03/05/2025
0.00
If you would invest  0.00  in Biotechnology Fund on September 6, 2024 and sell it all today you would earn a total of 0.00 from holding Biotechnology Fund Investor or generate 0.0% return on investment in Biotechnology Fund over 180 days. Biotechnology Fund is related to or competes with Health Care, Electronics Fund, Technology Fund, Financial Services, and Energy Services. Under normal circumstances, the fund invests substantially all of its net assets in equity securities of Biotechnology C... More

Biotechnology Fund Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biotechnology Fund's mutual fund current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biotechnology Fund Investor upside and downside potential and time the market with a certain degree of confidence.

Biotechnology Fund Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotechnology Fund's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biotechnology Fund's standard deviation. In reality, there are many statistical measures that can use Biotechnology Fund historical prices to predict the future Biotechnology Fund's volatility.
Hype
Prediction
LowEstimatedHigh
64.3166.3868.45
Details
Intrinsic
Valuation
LowRealHigh
60.0962.1673.02
Details

Biotechnology Fund Backtested Returns

Biotechnology Fund secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the fund had a -0.12 % return per unit of risk over the last 3 months. Biotechnology Fund Investor exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biotechnology Fund's Mean Deviation of 1.06, standard deviation of 1.99, and Risk Adjusted Performance of (0.08) to double-check the risk estimate we provide. The fund shows a Beta (market volatility) of -0.2, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Biotechnology Fund are expected to decrease at a much lower rate. During the bear market, Biotechnology Fund is likely to outperform the market.

Auto-correlation

    
  0.11  

Insignificant predictability

Biotechnology Fund Investor has insignificant predictability. Overlapping area represents the amount of predictability between Biotechnology Fund time series from 6th of September 2024 to 5th of December 2024 and 5th of December 2024 to 5th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biotechnology Fund price movement. The serial correlation of 0.11 indicates that less than 11.0% of current Biotechnology Fund price fluctuation can be explain by its past prices.
Correlation Coefficient0.11
Spearman Rank Test-0.02
Residual Average0.0
Price Variance17.72

Biotechnology Fund lagged returns against current returns

Autocorrelation, which is Biotechnology Fund mutual fund's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biotechnology Fund's mutual fund expected returns. We can calculate the autocorrelation of Biotechnology Fund returns to help us make a trade decision. For example, suppose you find that Biotechnology Fund has exhibited high autocorrelation historically, and you observe that the mutual fund is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Biotechnology Fund regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biotechnology Fund mutual fund is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biotechnology Fund mutual fund is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biotechnology Fund mutual fund over time.
   Current vs Lagged Prices   
       Timeline  

Biotechnology Fund Lagged Returns

When evaluating Biotechnology Fund's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biotechnology Fund mutual fund have on its future price. Biotechnology Fund autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biotechnology Fund autocorrelation shows the relationship between Biotechnology Fund mutual fund current value and its past values and can show if there is a momentum factor associated with investing in Biotechnology Fund Investor.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Biotechnology Mutual Fund

Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance